A Message to Our Customers and Partners Regarding COVID-19


Nanopharm to Host Webinar on April 21st Discussing In-Vitro Dissolution Testing for Orally-Inhaled Drug Products 阅读全文
Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination with ActivShieldTM 阅读全文
Aptar an Essential Partner to the Food, Healthcare and Consumer Products Industries During COVID-19 Pandemic 阅读全文